Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lymphoma × Data Collection × Clear all

Status

Terminated 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Pancreatic Neoplasms 3 Wilms Tumor 1 Uterine Cervical Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Rare Diseases 1 Prostatic Neoplasms 1 Pancreatic Cyst 1 Ovarian Neoplasms 1 Neuroblastoma 1 Nervous System Neoplasms 1 Multiple Myeloma 1 Lymphoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Intestinal Neuroendocrine Tumor 1 Frailty 1 Financial Stress 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1 Cognitive Dysfunction 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1 Brain Neoplasms 1 Bone Neoplasms 1

Interventions

Cyclophosphamide 26 fludarabine 18 Rituximab 13 obinutuzumab 10 Bendamustine Hydrochloride 9 venetoclax 7 Lenalidomide 7 pembrolizumab 5 Prednisone 5 Exercise 5 zanubrutinib 4 fludarabine phosphate 4 Mesna 4 Etoposide 4 Doxorubicin 4 Cytarabine 4 Blood Specimen Collection 4 Biopsy 4 tafasitamab 3 loncastuximab tesirine 3 glofitamab 3 axicabtagene ciloleucel 3 Vincristine 3 Trimethoprim, Sulfamethoxazole Drug Combination 3 Temozolomide 3 Radiotherapy 3 Palliative Care 3 Magnetic Resonance Spectroscopy 3 Interviews as Topic 3 Injections 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02869542 2016-08-17

Institut Paoli Calmettes Lymphoma Database

Institut Paoli-Calmettes

16,000 enrolled

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡